iBio, Inc. (IBIO): Net Income
-$33.04M
Year ended 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$33.04M | n/m | 2026-08-28, From 2025-07-01 |
| 2025-06-30 | -$18.38M | n/m | 2026-08-28, From 2024-07-01 |
| 2024-06-30 | -$24.91M | n/m | 2025-09-05, From 2023-07-01 |
| 2023-06-30 | -$65.01M | n/m | 2024-09-24, From 2022-07-01 |
| 2022-06-30 | -$50.30M | n/m | 2022-10-11, From 2021-07-01 |
| 2021-06-30 | -$23.21M | n/m | 2022-10-11, From 2020-07-01 |
| 2020-06-30 | -$16.44M | n/m | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | -$17.59M | n/m | 2020-10-13, From 2018-07-01 |
| 2018-06-30 | -$16.11M | n/m | 2019-08-26, From 2017-07-01 |
| 2017-06-30 | -$14.53M | n/m | 2018-09-18, From 2016-07-01 |
| 2016-06-30 | -$9.76M | n/m | 2017-09-15, From 2015-07-01 |
| 2015-06-30 | -$6.62M | n/m | 2016-10-13, From 2014-07-01 |
| 2014-06-30 | -$3.67M | n/m | 2015-10-13, From 2013-07-01 |
| 2013-06-30 | -$6.20M | n/m | 2014-09-29, From 2012-07-01 |
| 2012-06-30 | -$5.68M | n/m | 2013-10-04, From 2011-07-01 |
| 2011-06-30 | -$12.14M | n/a | 2012-10-15, From 2010-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| iBio, Inc. (IBIO) | 2026-06-30 | -$33.04M | n/m |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | -$33.89M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$6.50M | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$19.18M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.23M | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$84.95M | n/m |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | -$55.48M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$78.26M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$16.59M | n/m |
Compare IBIO, ATNM, BFRG, SER side by side · Screen every company in Pharmaceutical Preparations ↗